Natural Killer (NK) Cell Therapy in Locally Advanced HCC

NCT05040438 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Vaxcell Bio, Co., Ltd.